New Zealand markets closed

NeonMind Biosciences Inc (6UF0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0120-0.0030 (-20.00%)
At close: 06:59PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/11/2022
30/11/2021
30/11/2020
Total revenue
0
0
0
0
Cost of revenue
-
-
-
0.25
Gross profit
-
-
-
415.553
Operating expenses
Research development
2.5
149.018
1,356
28.023
Selling general and administrative
371.269
1,483
5,957
1,030
Total operating expenses
421.149
1,751
7,776
1,063
Operating income or loss
-421.149
-1,751
-7,776
-1,063
Interest expense
228.462
279.509
33.437
132.819
Total other income/expenses net
537.58
-3.473
1,125
-971.564
Income before tax
-112.031
-2,034
-6,684
-2,168
Income from continuing operations
-112.031
-2,034
-6,684
-2,168
Net income
-112.031
-2,034
-7,208
-2,677
Net income available to common shareholders
-112.031
-2,034
-7,208
-2,677
Basic EPS
-0.01
-1.80
-13.60
-2.86
Diluted EPS
-0.01
-1.80
-13.60
-2.86
Basic average shares
1,165
1,132
983.299
936.92
Diluted average shares
1,166
1,132
983.299
936.92